Category Archives: Science

Science Press Releases & News distributed via EuropaWire

GRAHAM Gains SBTi Validation, Advancing Climate Leadership in Construction with Ambitious Net Zero Goals

(IN BRIEF) GRAHAM has received validation from the Science Based Targets initiative (SBTi) for its net zero greenhouse gas reduction targets, aligning its climate goals with the Paris Agreement’s 1.5°C target. This endorsement positions GRAHAM among a select few in … Read the full press release

Fresenius Medical Care Recognized Among Top 100 Women-Led Businesses in Massachusetts Under CEO Helen Giza’s Leadership

(IN BRIEF) Fresenius Medical Care (FME), a global leader in renal healthcare, has earned a spot at #4 on Massachusetts’ Top 100 Women-Led Businesses list, compiled by The Women’s Edge and The Boston Globe. CEO Helen Giza’s leadership has been … Read the full press release

Newcastle and Northumbria Universities Reaffirm Collaborative Commitment to Strengthen City’s Future

(IN BRIEF) Newcastle and Northumbria universities have renewed their partnership through the Collaborative Newcastle Universities Agreement, aiming to support Newcastle’s health, economic growth, and environmental sustainability. This partnership focuses on community initiatives like expanding educational access, promoting student well-being, and … Read the full press release

TU/e and Catharina Hospital Use Digital Twins to Shape the Future of Personalized Heart Care

(IN BRIEF) Researchers from Eindhoven University of Technology (TU/e) and Catharina Hospital, including cardiologist Prof. Lukas Dekker and PhD candidate Carlijn Buck, are pioneering the use of “digital twins” to advance personalized care for heart patients. This innovative approach creates … Read the full press release

Accenture and 1910 Genetics Unite to Revolutionize Drug Discovery with AI-Driven Solutions

(IN BRIEF) Accenture has invested in 1910 Genetics, a biotech firm leveraging AI-driven lab automation to enhance drug discovery for small and large molecule therapies. This partnership aims to provide biopharma clients with a powerful AI platform, streamlining the drug … Read the full press release

Roche’s Itovebi Regimen Shows Significant Survival Benefits for HR-Positive Breast Cancer in Phase III Trial Results

(IN BRIEF) Roche announced the publication of pivotal phase III results for its Itovebi™ (inavolisib)-based regimen at the Clinical Trials in Alzheimer’s Disease congress, demonstrating a 57% reduction in the risk of disease progression or death in patients with HR-positive, … Read the full press release

Roche Showcases Advancements in Alzheimer’s Diagnostics at CTAD 2024

(IN BRIEF) At the CTAD 2024 congress in Madrid, Roche presented new data on its Elecsys® Amyloid Plasma Panel and Elecsys ptau181, demonstrating their effectiveness in diagnosing Alzheimer’s disease. The blood-based test showed a negative predictive value of 96.2% in … Read the full press release

Rising Ocean Temperatures Threaten North Atlantic Seaweed Farms, Scientists Urge for Enhanced Resilience Measures

(IN BRIEF) Scientists from the Scottish Association for Marine Science (SAMS) warn that climate change may threaten key seaweed species in the North Atlantic, potentially reducing yields of cold-affiliated species like Alaria esculenta and Laminaria digitata by 2070. As ocean … Read the full press release

Kantonsspital Baden and Siemens Transform Swiss Healthcare with Cutting-Edge Smart Hospital Platform

(IN BRIEF) Kantonsspital Baden (KSB) is set to become one of Switzerland’s leading smart hospitals through a collaboration with Siemens Smart Infrastructure, which will deploy its Siemens Xcelerator platform. This advanced IoT system, comprising over 7,000 sensors and 2,000 smart … Read the full press release

Early Surgery for Aortic Stenosis Could Prevent Symptoms and Hospital Visits, Study Finds

(IN BRIEF) A new study from the University of Edinburgh and the University of East Anglia suggests that earlier surgical intervention for severe aortic stenosis can improve elderly patients’ quality of life and reduce hospitalizations. The EVOLVED study, involving 224 … Read the full press release

RWE Launches Ecosystem-Based Monitoring at Kaskasi Offshore Wind Farm with Marine Science Experts

(IN BRIEF) RWE has partnered with leading marine scientists to launch the SeaMe project at its Kaskasi offshore wind farm, aiming to monitor biodiversity through an ecosystem-based approach. This three-year initiative employs advanced monitoring tools like AI-driven drones, underwater vehicles, … Read the full press release

TUM Researchers Develop New Method to Boost Zinc Battery Lifespan, Advancing Large-Scale Energy Storage

(IN BRIEF) Researchers at the Technical University of Munich (TUM) have developed a new chemical method that dramatically extends the lifespan of zinc-ion batteries, potentially reaching hundreds of thousands of charge cycles. This innovation uses a special protective layer on … Read the full press release

QIAGEN Gains FDA Approval for QIAstat-Dx Mini Panel, Enhancing Outpatient Respiratory Diagnostics with Rapid Results

(IN BRIEF) QIAGEN has announced FDA clearance for its QIAstat-Dx Respiratory Panel Mini, marking the third such approval for the QIAstat-Dx system in 2024. Tailored for outpatient settings, this panel quickly detects five common respiratory pathogens—including influenza strains and SARS-CoV-2—enabling … Read the full press release

AstraZeneca’s Fasenra Approved in EU for Treating Rare Vasculitis, Offering New Hope for EGPA Patients

(IN BRIEF) AstraZeneca’s Fasenra (benralizumab) has been approved in the European Union as an add-on treatment for adults with eosinophilic granulomatosis with polyangiitis (EGPA), a rare and severe form of vasculitis. The approval follows positive results from the MANDARA Phase … Read the full press release

Empa Researchers Unveil Key Insights into “Superspreader” Protein Fibrils in Alzheimer’s

(IN BRIEF) Empa researchers, in collaboration with the University of Limerick, have identified a highly active type of protein fibril, termed “superspreader,” that may play a key role in the progression of Alzheimer’s disease. Using advanced atomic force microscopy, they … Read the full press release

Thales and Max Planck Institute Set Fusion Milestone with Record-Breaking Gyrotron Power Output

(IN BRIEF) Thales and the Max Planck Institute for Plasma Physics have achieved a new milestone in nuclear fusion by setting a world record with Thales’s TH1507U gyrotron, which generated 1.3 megawatts of radiofrequency for 360 seconds. Developed for the … Read the full press release

Orano Commits to Supporting Cancer Prevention and Employee Well-being by Joining “Working with Cancer” Initiative

(IN BRIEF) Orano has signed the “Working with Cancer” pledge, joining a global initiative led by Publicis Chair and CEO Arthur Sadoun to promote cancer prevention and support employees affected by cancer. The pledge reflects Orano’s commitment to employee well-being … Read the full press release

Ahlstrom Unveils Lipid Saver™: A Sustainable Innovation for Fatty Acid Collection and Storage

(IN BRIEF) Ahlstrom has introduced Lipid Saver™, a new solution designed for the collection, transport, and storage of fatty acids from whole blood samples. The innovative card allows for easy sample collection and long-term preservation at room temperature, eliminating the … Read the full press release

University of Exeter Researchers Receive £400,000 Grant to Advance Innovative Type 1 Diabetes Treatments

(IN BRIEF) Researchers at the University of Exeter have been awarded nearly £400,000 from the Type 1 Diabetes Grand Challenge to explore innovative treatments for type 1 diabetes. Led by Dr. Craig Beall and Dr. Tom Piers, the project will … Read the full press release

Lifecare Transitions to Euronext Oslo Børs as It Moves Closer to Market with Innovative Diabetes Technology

(IN BRIEF) Lifecare, a Norwegian medtech company developing implantable sensors for glucose and biomarker monitoring, has transitioned from Euronext Growth Oslo to the main Euronext Oslo Børs market. This marks a significant milestone for the company, with a market capitalization … Read the full press release

SAMS Expands Research Team with New Roles to Tackle Ocean Changes and Climate Impact

(IN BRIEF) The Scottish Association for Marine Science (SAMS) is expanding its research team with five new positions to enhance its understanding of ocean processes, particularly in response to climate change, biodiversity loss, and pollution. The new hires, including principal … Read the full press release

Neuberger Berman, EQT, and CPP Investments Lead USD 14.5 Billion Acquisition of Nord Anglia Education

(IN BRIEF) Neuberger Berman, EQT, and CPP Investments, along with a consortium of global investors, have signed agreements to acquire Nord Anglia Education for USD 14.5 billion. Nord Anglia, a leading international schools organization with over 80 schools in 33 … Read the full press release

Wainzua Receives EU Recommendation for Treating Hereditary Amyloidosis, Offering New Monthly Self-Administered Option

(IN BRIEF) AstraZeneca and Ionis’ drug Wainzua (eplontersen) has been recommended for approval in the European Union for treating hereditary transthyretin-mediated amyloidosis (ATTRv-PN) in adults with stage 1 or 2 polyneuropathy. Based on the positive results from the NEURO-TTRansform Phase … Read the full press release

GSK and Cambridge University Join Forces with £50 Million Investment to Tackle Kidney and Respiratory Diseases Using AI

(IN BRIEF) GSK and the University of Cambridge have announced a £50 million, five-year collaboration called the Cambridge-GSK Translational Immunology Collaboration (CG-TIC) to accelerate research and development in kidney and respiratory diseases. The initiative combines GSK’s expertise in immunology and … Read the full press release

Novo Nordisk’s Oral Semaglutide Reduces Cardiovascular Risk by 14% in Type 2 Diabetes Patients, SOUL Trial Shows

(IN BRIEF) Novo Nordisk’s SOUL trial has shown that oral semaglutide reduces the risk of major adverse cardiovascular events (MACE) by 14% in adults with type 2 diabetes and established cardiovascular disease or chronic kidney disease. The trial involved 9,650 … Read the full press release

Sanofi and CD&R Join Forces to Propel Opella’s Global Consumer Healthcare Expansion

(IN BRIEF) Sanofi and CD&R have entered exclusive negotiations for CD&R to acquire a 50% controlling stake in Opella, Sanofi’s consumer healthcare business, while Sanofi retains a significant share. The partnership aims to support Opella’s growth as a global leader … Read the full press release

University of York Researchers Investigate the Threat of Climate Change and Flooding on Earthworm Populations

(IN BRIEF) Researchers at the University of York, led by Professor Mark Hodson, are launching a two-year study to examine how climate change and increasing flooding in the UK are affecting earthworm populations. Earthworms play a vital role in maintaining … Read the full press release

Novo Nordisk’s Alhemo® Recommended for European Approval as First Once-Daily Subcutaneous Treatment for Haemophilia A and B with Inhibitors

(IN BRIEF) Novo Nordisk’s Alhemo® (concizumab) has been recommended for approval by the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP). If approved, Alhemo® will become the first once-daily subcutaneous prophylactic treatment for people aged 12 … Read the full press release

Sanofi and Orano Med Partner to Drive Development of Advanced Radioligand Cancer Therapies

(IN BRIEF) Sanofi and Orano Med have partnered to accelerate the development of next-generation radioligand therapies (RLTs) for rare cancers. By combining their expertise, they aim to advance treatments using lead-212 (212Pb) alpha-emitting isotopes, which target and destroy cancer cells … Read the full press release

German Researchers Advance 6G Technology with Focus on Security, Digital Twins, and Telediagnostics

(IN BRIEF) Researchers at the Technical University of Munich (TUM) and TU Dresden are leading initiatives to develop 6G mobile communication technologies, with commercial availability expected by 2030. These projects focus on key advancements such as digital twins for reliable … Read the full press release

Aalborg University Researchers Discover Genetic Marker Linked to Severe Ulcerative Colitis, Paving the Way for Personalized Treatment

(IN BRIEF) Researchers have identified the genetic variant HLA-DRB1*01:03, which is strongly linked to severe ulcerative colitis. About 3% of patients carry this variant, and of those, over 40% required major surgery within three years of diagnosis. (PRESS RELEASE) AALBORG, … Read the full press release

AstraZeneca Presents New Data at IDWeek 2024, Showcasing Progress in Respiratory Disease Prevention and Vaccine Innovation

(IN BRIEF) AstraZeneca presented significant advancements in the prevention of infectious diseases at IDWeek 2024, showcasing its dedication to addressing respiratory infections caused by RSV, hMPV, and COVID-19. The company revealed promising data across its portfolio, including Beyfortus, an antibody … Read the full press release

University of York Alumnus Daron Acemoglu Wins Nobel Prize for Research on Economic Prosperity and Institutions

(IN BRIEF) University of York alumnus Daron Acemoglu has been awarded the Nobel Prize in Economic Sciences, alongside Simon Johnson and James A. Robinson, for their research on how societal institutions influence a country’s economic prosperity. Their work highlights the … Read the full press release

Fresenius Medical Care Unveils Xenios 2.0: Next-Generation ECLS System with Advanced Safety and Connectivity Features

(IN BRIEF) Fresenius Medical Care’s subsidiary, Xenios AG, has launched Xenios 2.0, a new system for extracorporeal life support (ECLS) that serves patients from neonates to adults. Approved under the new Medical Device Regulation (MDR), Xenios 2.0 offers advanced safety … Read the full press release

BASF and Acadian Plant Health Partner to Launch Seaweed Biostimulants for Climate-Resilient Farming

(IN BRIEF) BASF has partnered with Acadian Plant Health™ to expand its BioSolutions portfolio by incorporating seaweed-based biostimulants. These biostimulants, derived from Ascophyllum nodosum, help crops withstand stressors like heat and drought, supporting sustainable agriculture. The collaboration will distribute these … Read the full press release

EIB Global Invests €2 Million in Vaccine Development at Akagera Medicines in Rwanda

(IN BRIEF) The European Investment Bank (EIB Global) has committed €2 million to support Akagera Medicines Africa Limited in Rwanda, facilitating the early-stage development of vaccines for infectious diseases, including tuberculosis, HIV, Ebola, and Lassa fever. This funding aims to … Read the full press release

Eviden Unveils Innovative “Cloud for Clinics” Platform to Transform Healthcare in DACH Region

(IN BRIEF) Eviden, a division of the Atos Group, has unveiled its “Cloud for Clinics,” a secure and pre-integrated platform tailored for healthcare providers in Germany and the DACH region, built on Amazon Web Services (AWS). This initiative aims to … Read the full press release

University of Liverpool and Roche Diagnostics Unite to Drive Health Innovation and Address Inequalities

(IN BRIEF) The University of Liverpool has signed a Memorandum of Understanding (MoU) with Roche Diagnostics UK and Ireland to enhance research and innovation focused on improving health outcomes and addressing health inequalities. This partnership aims to align with Roche’s … Read the full press release

GSK Reports Promising Phase III Findings for Depemokimab in Treating Chronic Rhinosinusitis with Nasal Polyps

(IN BRIEF) GSK plc has announced positive results from its Phase III ANCHOR trials for depemokimab, a biologic treatment for chronic rhinosinusitis with nasal polyps (CRSwNP). The trials demonstrated a significant reduction in nasal polyp size and nasal obstruction after … Read the full press release

Roche’s Evrysdi Shows Remarkable Motor and Cognitive Outcomes in Children with SMA After Two Years of Early Treatment

(IN BRIEF) Roche has announced positive two-year data from its RAINBOWFISH study, showcasing the effectiveness of Evrysdi® (risdiplam) in treating children with spinal muscular atrophy (SMA) when administered before symptoms appear. The study revealed that most children achieved key motor … Read the full press release